SONBAXTI

Serial Number 98429266
730

Registration Progress

Application Filed
Mar 1, 2024
Under Examination
Dec 10, 2024
Approved for Publication
Oct 29, 2024
Published for Opposition
Oct 29, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Dec 10, 2025 37 days

Trademark Image

SONBAXTI

Basic Information

Serial Number
98429266
Filing Date
March 1, 2024
Published for Opposition
October 29, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
May 16, 2025
Application
Pending
Classes
005

Rights Holder

BEONE MEDICINES I GMBH

16
Address
AESCHENGRABEN 27
BASEL 4051
CH

Ownership History

BeiGene Switzerland GMBH

Original Applicant
03
Basel CH

BeiGene Switzerland GMBH

Owner at Publication
03
Basel CH

BEONE MEDICINES I GMBH

New Owner After Publication #1
16
BASEL CH

Legal Representation

Attorney
Kristen S. Ruisi

USPTO Deadlines

Next Deadline
37 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
December 10, 2025
Extension Available
Until December 10, 2025

Application History

15 events
Date Code Type Description Documents
Jul 10, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 9, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 4, 2025 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
May 17, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 16, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 16, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
May 16, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 10, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 29, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 29, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 9, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 24, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 17, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 1, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 1, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases

Classification

International Classes
005